The Weil Institute Welcomes Dr. Geoffrey Ling!
Day: October 10, 2023
Time: 11:00 AM - 12:00 PM followed by networking lunch from 12:00-1:00 PM
Location: Michigan Union Floor 1 - Kuenzel Ballroom
Title: Saying Yes
Overview: DARPA is a federal funding agency that creates capabilities. To do this, the agency has created a unique approach within the government which is to look for ways to say "yes." The result has been some remarkable technological advances.
-
Geoffrey Ling, M.D., Ph.D. is Professor of Neurology at Johns Hopkins. He received his MD from Georgetown and PhD in Pharmacology from Cornell and an honorary DSci from the Elmezzi School of Molecular Medicine.. His completed his residency in neurology at Walter Reed Army Medical Center, his neuro critical care fellowship at Johns Hopkins and his neuropharmacology fellowship at Memorial Sloan-Kettering Cancer Center.
He is a retired U.S. Army medical officer who served on active duty for 21 years. He was deployed as an intensive care physician with the 452nd CSH (combat support hospital) in OEF-Afghanistan (2003) and 86th CSH and 10th CSH in OIF-Iraq (2005). Also, COL Ling has had four in-theater missions as a member of the Joint Chiefs of Staff “Gray Team” to assess traumatic brain injury (TBI) care in both combat theaters. The 10th CSH named him their first “Physician of the Month.” Dr. Ling was also a “requested by name” consultant to Congresswoman Gabby Gifford’s trauma team following her tragic attack.
He was the Founding Director of the Biological Technologies Office (BTO) at the Defense Advanced Research Projects Agency (DARPA), where he had served as a program manager and then Deputy Director of the Defense Sciences Office (DSO).
Dr. Ling is the co-founder and was the CEO of On Demand Pharmaceuticals, which is a company developing point-of-care medicine manufacturing technology. This company is currently valued at $250M and has over 100 employees.
Dr. Ling also served as an Assistant Director for Medical Innovation in the Science Division of President Obama’s White House Office of Science, Technology and Policy (OSTP). He assisted in organizing and launching the President’s BRAIN and combatting combat Antibiotic Resistance Bacteria (ARB) initiatives.
He has published over 200 peer-reviewed journal articles and book chapters, mainly in the fields of traumatic brain injury and opioids. He served on the Advisory Councils of the NIH-National Institute of Neurological Disorders and Strokes, the NIH-National Center for Advanced Translation Science and the Veterans Administration’s National Research Advisory Council, which he chaired. He is presently on the NFL’s Health Foundation Board of Directors and the NFLPA’s Health committee.